Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Cholecalciferol in Pediatric CF
NCT02613884Phase 2Completed
- Sponsor
- Johns Hopkins All Children's Hospital
- Start
- Nov 2016
- Primary completion
- Nov 2019
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vitamin d in Vitamin D deficiency (VDD), sponsored by Johns Hopkins All Children's Hospital. Primary endpoint: Safety of a Single High-dose of Oral Cholecalciferol at 3 months. Started Nov 2016; status: completed.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT02613884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02613884.